Literature DB >> 20865265

Poor coronary collateral vessel development in patients with mild to moderate renal insufficiency.

Shuang-lun Xie1, Hai-yan Li, Bing-qing Deng, Nian-sang Luo, Deng-feng Geng, Jing-feng Wang, Ru-qiong Nie.   

Abstract

BACKGROUND: The development of coronary collaterals is crucial to survival through acute ischemia. Mild to moderate loss of renal function has been suggested to play a role in this event, but evidential data are scarce. The aim of this study was to investigate the relationship between mild to moderate renal insufficiency and coronary collateral development in patients with chronic total coronary artery occlusion. METHODS AND
RESULTS: A total of 83 patients with mild to moderate loss of renal function (30 mL/min/1.73 m(2) ≤ eGFR < 90 mL/min/1.73 m(2)) with chronic total coronary artery occlusion were included in our study. The collateral circulation was graded according to Rentrop classification and the function of collateral circulation was graded according to Werner collateral connection (CC) grades. Compared to patients with good collateral circulation (Rentrop = 2,3), eGFR was found to be lower in those patients with poor coronary collateral circulation (Rentrop = 0,1) (63.30 ± 10.51 vs. 54.13 ± 10.56, P = 0.02). eGFR was also found to be lower in poorly functioning coronary collateral circulation (CC = 0,1) than in efficiently functioning coronary collateral circulation (CC = 2) (55.22 ± 9.98 vs. 66.28 ± 9.16, P = 0.03). Multiple logistic regression analysis showed that low eGFR was independently associated with poor coronary collateral circulation (Rentrop = 0,1, 95% CI, 0.09-1.09, P = 0.044) and poor function of coronary collateral circulation (CC = 0,1, 95% CI, 0.02-0.17, P = 0.02).
CONCLUSIONS: Lower eGFR is associated with poorer coronary collateral vessel development in patients experiencing mild to moderate renal insufficiency. Moreover, eGFR represents an independent factor affecting coronary collateral vessel development.

Entities:  

Mesh:

Year:  2010        PMID: 20865265     DOI: 10.1007/s00392-010-0233-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  36 in total

1.  Can we prevent end-stage renal disease due to hypertension or to diabetes mellitus?

Authors:  R G Luke
Journal:  JAMA       Date:  1992-12-02       Impact factor: 56.272

2.  Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure.

Authors:  M Akmal; S E Kasim; A R Soliman; S G Massry
Journal:  Kidney Int       Date:  1990-03       Impact factor: 10.612

3.  Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.

Authors:  Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.

Authors:  Frank Stam; Coen van Guldener; Annemarie Becker; Jacqueline M Dekker; Robert J Heine; Lex M Bouter; Coen D A Stehouwer
Journal:  J Am Soc Nephrol       Date:  2005-12-28       Impact factor: 10.121

6.  Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study.

Authors:  Ronald M A Henry; Piet J Kostense; Griët Bos; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter; Coen D A Stehouwer
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

Review 7.  Regulation of coronary blood flow during exercise.

Authors:  Dirk J Duncker; Robert J Bache
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

8.  Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.

Authors:  Stephan H Schirmer; Joost O Fledderus; Pieter T G Bot; Perry D Moerland; Imo E Hoefer; Jan Baan; José P S Henriques; René J van der Schaaf; Marije M Vis; Anton J G Horrevoets; Jan J Piek; Niels van Royen
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

9.  Small arterial elasticity predicts the extent of coronary artery disease: Relationship with serum uric acid.

Authors:  Murat Fazlioğlu; Tunay Sentürk; Ethem Kumbay; Aysel Aydin Kaderli; Yusuf Yilmaz; Bülent Ozdemir; Ibrahim Baran; Ali Aydinlar
Journal:  Atherosclerosis       Date:  2008-04-22       Impact factor: 5.162

Review 10.  Management of hypertension in patients with chronic kidney disease and diabetes mellitus.

Authors:  Biff F Palmer
Journal:  Am J Med       Date:  2008-08       Impact factor: 4.965

View more
  9 in total

1.  Comment on: renal impairment and coronary collaterals in patients with acute coronary syndrome.

Authors:  Sevket Balta
Journal:  Herz       Date:  2014-06       Impact factor: 1.443

2.  Association of Systolic Blood Pressure and Cerebral Collateral Flow in Acute Ischemic Stroke by Stroke Subtype.

Authors:  Jae Eun Sim; Jong-Won Chung; Woo-Keun Seo; Oh Young Bang; Gyeong-Moon Kim
Journal:  Front Neurol       Date:  2022-05-13       Impact factor: 4.086

3.  Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion.

Authors:  Zhen Sun; Ying Shen; Lin Lu; Rui-yan Zhang; Li-jin Pu; Qi Zhang; Zheng-kun Yang; Jian Hu; Qiu-jing Chen; Wei-feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

4.  Renal impairment and coronary collaterals in patients with acute coronary syndrome.

Authors:  M Duran; O K Uysal; O Gunebakmaz; Y Yilmaz; M A Vatankulu; M Turfan; A O Duran; E Ornek; M Cetin; S N Murat; M G Kaya
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

5.  Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease.

Authors:  Po-Chao Hsu; Suh-Hang Juo; Ho-Ming Su; Szu-Chia Chen; Wei-chung Tsai; Wen-Ter Lai; Sheng-Hsiung Sheu; Tsung-Hsien Lin
Journal:  BMC Nephrol       Date:  2012-08-30       Impact factor: 2.388

6.  Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.

Authors:  Ying Shen; Feng Hua Ding; Rui Yan Zhang; Qi Zhang; Lin Lu; Wei Feng Shen
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

7.  Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.

Authors:  Ying Shen; Lin Lu; Feng Hua Ding; Zhen Sun; Rui Yan Zhang; Qi Zhang; Zheng Kun Yang; Jian Hu; Qiu Jing Chen; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2013-11-08       Impact factor: 9.951

Review 8.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951

9.  Inverse association of diabetes and dialysis with the severity of femoropopliteal lesions and chronic total occlusion: a cross-sectional study of 2056 cases.

Authors:  Mitsuyoshi Takahara; Yoshimitsu Soga; Masahiko Fujihara; Daizo Kawasaki; Amane Kozuki; Osamu Iida
Journal:  BMC Cardiovasc Disord       Date:  2020-12-09       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.